Best Lymph Node Biopsy or Excision Doctors in Teaneck, NJ

I am a surgeon who specializes in nerve-sparing radical prostatectomy for the treatment of prostate cancer, and 'salvage' radical prostatectomy in patients with prostate cancer in whom radiation therapy has failed. My clinical research focuses on improving outcomes (such as cancer control, urinary continence, and sexual function) following surgery for prostate cancer. Together with my colleagues in medical oncology and radiation oncology, we attempt to tailor therapy more accurately to each individual's cancer in order to control cancer spread and decrease treatment-related side effects.

Click here to view New York Times article on Dr. Michelassi's strictureplasty for crohns disease.

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Dr Tassler is a specialist in all aspects of head and neck cancer surgery His expertise lies in the diagnosis and treatment of benign and malignant tumors of the head and neck including salivary glands thyroid and parathyroid tongue lips and oral

Jeffrey Milsom, MD, FACS, has unique expertise and unparalleled experience in minimally invasive surgery for complex colorectal diseases.Dr. Milsom is the lead inventor of the endoluminal surgical platform, commercially known as the DiLumen, which stabilizes the colon to allow for endoscopic procedures of greater complexity, thereby avoiding surgery for some patients.He has performed close to 2,000 laparoscopic colon and rectal operations, and has been invited to perform surgeries in over 15 countries. Under Dr. Milsom's leadership, 90 percent of all procedures in the Colon and Rectal Section at New York Presbyterian-Weill Cornell Medical Center are now performed using high-tech, minimally invasive technologies. He has published four books, 24 book chapters and over 250 papers, presentations and educational videos.He is a member of 14 prestigious professional societies, and is a Fellow at the American Society of Colon & Rectal Surgeons, the American College of Surgeons and the Society of Surgical Oncology.After graduating summa cum laude from the University of Pennsylvania, Dr. Milsom received his medical degree from the University of Pittsburgh in 1979. He fulfilled two years of residency at Roosevelt Hospital in New York and completed his residency at the University of Virginia Medical Center, where he served as Chief Resident. He concluded his advanced training as a Fellow in Colon and Rectal Surgery at the Ferguson Clinic, Grand Rapids, Michigan in 1985, and has been a board certified colon and rectal surgeon since 1986. He joined the faculty of New York Presbyterian-Weill Cornell Medical Center in 2001.Dr. Milsom was Assistant Professor of Surgery at Michigan State University in East Lansing, Michigan from 1986 through 1989. During this period he was also the Director, Department of Surgical Research at the Ferguson Clinic. From 1990 to 1998, he was the Director of Research, Department of Colorectal Surgery at the Cleveland Clinic Foundation and from 1997 through 1998 he was also the Director of Research, Minimally Invasive Surgery Center at the Cleveland Clinic. In April 1998, Dr. Milsom became a Professor of Surgery at The Mount Sinai Medical Center in New York, Chief of the Division of Colorectal Surgery and Co-Director of Minimally Invasive Surgery.Reflecting his strong interest and expertise, Dr. Milsom currently serves as an active member of the hospital's Operating Room New Technology Committee and the Minimal Access Surgical Committee. Dr. Milsom has been recruited to participate in numerous national committees, including the Laparoendoscopic Surgical Education Committee as part of the Association of Program Directors for Colon & Rectal Surgery and the Membership Committee of the Society of American Gastrointestinal Endoscopic Surgeons.He served on the Emerging Technologies Committee for the American Society of Colon & Rectal Surgeons. Dr. Milsom is also a senior examiner for the American Board of Colon and Rectal Surgeons. He is a reviewer for Surgical Endoscopy, Diseases of the Colon & Rectum, Annals of Surgery and serves as a senior editor of WebSurg.PubMed

Joshua R. Sonett MD FACS is the Edward C. and Anne K. Weiskopf Professor of Surgical Oncology (in Surgery) at CUMC, Chief of General Thoracic Surgery and Director, The Price Family Center for Comprehensive Chest Care, Lung and Esophageal Center. He is instrumental in making the Thoracic Surgery section at Columbia University Medical Center one of the best in the U.S. and he is one of the youngest professors of surgery at a major academic institution in the United States. Dr. Sonett is best known for his work on the multidisciplinary treatment of lung and esophageal malignancies. Leading work in minimally invasive treatment of lung and esophageal cancer, Dr. Sonett and his team at Columbia are innovators in the development and teaching techniques of Video Assisted Thoracic Surgery (VATS) and Minimally Invasive Esophageal (MIE) surgery, allowing surgeons to incorporate these techniques into their daily practices. Dr. Sonett and his team make up one of the few programs in the country to employ a combination of maximal chemo and radiation and surgical therapies in the treatment of locally advanced lung malignancies. He is also a leader in multi-modality therapies for lung and esophageal cancers, and a pioneer in endo-bronchial palliation of benign and malignant airway stenosis. In the clinical area of lung transplantation, Dr. Sonett is best known for developing an extended-donor lung transplant criteria protocol. Extended donor criteria (EDC) applies to the use of organs that don't meet the usual criteria for transplantation due to various health problems, but are still healthy enough for a successful transplant (Liver MD 2006). Dr. Sonett and his team have been aggressively trying to alleviate the donor shortage by evaluating lungs that may be rejected from other centers (CS News 2005). Between 2001 and 2003, 53 percent of the lungs transplanted at NewYork-Presbyterian/Columbia were extended donor criteria lungs, with no difference in survival between EDC lung recipients and regular lung recipients. The Columbia programs has a 95% survival rate after one year and 83% after three years, which far surpasses the national average of 79% and 62% respectively (CS Lung News 2006). Dr. Sonett has been an invited speaker and principal and co- investigator of numerous clinical trials, author of numerous publications in renown journals such as the Journal of The American College of Cardiology, Annals of Thoracic Surgery, and the Journal of Heart and Lung Transplant, among many others. Dr. Sonett received his MD from Brody School of Medicine at East Carolina University Medical School, and completed his surgical residency at the University of Massachusetts, and Thoracic Fellowship at the University of Pittsburgh Medical Center. Professional Memberships include the New York Thoracic Society, The Society of Thoracic Surgeons, Fellow of the American College of Surgeons and member of the American Association for Thoracic Surgeons Dr. Sonett has received numerous award and honors including annual awards to America's Top Doctors, Castle Connolly America's Top Doctors for Cancer, New York Magazine's Best Doctors, the Barbara Neibauer Celebration of Life Award, Foundation for Thymic Cancer and the Humanitarian Award, Chesed of New Square.